R
RK Will Pty Ltd | Victoria Park, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tofacitinib
Adalimumab
Methotrexate
Tanezumab
Filgotinib
BMS-986165
Deucravacitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 8 total trials
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...
Enrolling
Systemic Lupus Erythematosus
Drug: Deucravacitinib
Other: Placebo
The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the...
Active, not recruiting
Rheumatoid Arthritis
Drug: Filgotinib
Drug: Placebo to match filgotinib
Trial sponsors
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems